Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Für diesen Artikel ist leider kein Bild verfügbar.

2026 Nurse's Drug Handbook

Buch | Softcover
1630 Seiten
2025 | 25th Edition
Jones and Bartlett Publishers, Inc (Verlag)
978-1-284-31488-5 (ISBN)
CHF 69,80 inkl. MwSt
  • Versand in 10-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Take 2026 Nurse's Drug Handbook wherever you go with the convenient and easy-to-use app for Android and Apple. Subscribe Today to Start a FREE Trial! The 2026 Nurse's Drug Handbook is an up-to-date, practical, comprehensive and user-friendly drug reference guide for current nursing students and practicing nurses alike. Written in a straightforward style with approachable terminology, it offers concise and consistently formatted drug entries organized alphabetically from A-Z. The 2026 Nurse's Drug Handbook ensures that all nurses, both new and experienced, can easily access accurate information they need before administering any medication, ensuring proper patient care and safety. The 2026 Nurse's Drug Handbook includes:

Generic and trade names and, if applicable, alternative drug names
Pharmacologic and therapeutic classes Indications and Dosages with, if applicable, dosage adjustments
Drug Administration guidelines for each form of drug to be administered
Onset, peak, and duration along with half-life for each form of drug
Mechanism of Action Contraindications Interactions for drugs, activities, and foods
Adverse drug reactions with life-threatening ones bolded
Childbearing Considerations with subcategories of pregnancy and lactation for all drugs; if applicable, labor and delivery and reproduction subcategories
Nursing Considerations with warnings highlighted by bolded Warning word and warning appears in a different color
Patient Teaching with warnings highlighted by bolded Warning word and warning appears in a different color
New drugs added to the 2026 Nurse's Drug Handbook include: Aprocitentan, Benzgalantamine, Ceftobiprole Medocaril Sodium, Deuruxolitinib, Deutetrabenazine, Donanemab-Azbt, Ensifentrine, Fezolinetant, Landiolol, Lebrikizumab-Lbkz, Nalmefene Hcl, Nemolizumab-Ilto, Pivmecillinam

Founded in 1983, Jones & Bartlett Learning is a world-leading provider of instructional, assessment, and learning-performance management solutions for the secondary education, post-secondary education, and professional markets. We develop educational programs and services that improve learning outcomes and enhance student achievement by combining authoritative content written by respected authors with innovative, proven, and engaging technology applications that meet the diverse needs of today's instructors, students, and professionals.'

Erscheinungsdatum
Verlagsort Sudbury
Sprache englisch
Gewicht 1814 g
Themenwelt Medizin / Pharmazie Pflege Ausbildung / Prüfung
ISBN-10 1-284-31488-X / 128431488X
ISBN-13 978-1-284-31488-5 / 9781284314885
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Christine Keller; Agnetha Radatz

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 25,20